| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0213 |
| 1 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 2 | 0.0097 |
| 2 | TALETRECTINIB | 1 | 0.0092 |
| 3 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 27 | 0.0040 |
| 5 | ENALAPRILAT | 1 | 0.0039 |
| 6 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 7 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 29 | 0.0032 |
| 8 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 30 | 0.0030 |
| 9 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 26 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytochrome P450 3A Inhibitor [EPC] | 51 | 0.0008 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 86 | 0.0008 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 18 | 0.0007 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 5 | 0.0005 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Protease Inhibitor [EPC] | 12 | 0.0003 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Cannabinoid [EPC] | 2 | 0.0002 |
| 9 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |